| Literature DB >> 23793664 |
Dianne P Goeman1, Michael J Abramson, Edwina A McCarthy, Celia M Zubrinich, Jo A Douglass.
Abstract
OBJECTIVE: As previous asthma mortality studies were undertaken between 1986 and 1997, and treatments have evolved since that time, in order to direct future asthma interventions, we investigated the reasons for asthma deaths between 2005 and 2009.Entities:
Keywords: Health Services Administration & Management; Preventive Medicine; Primary Care
Year: 2013 PMID: 23793664 PMCID: PMC3657652 DOI: 10.1136/bmjopen-2012-002539
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Asthma deaths/rate per 100000 in Australia by age from 2005 to 2008
| Age | 2005 | 2006 | 2007 | 2008 | Overall |
|---|---|---|---|---|---|
| 0–9 | 3 | 0 | 1 | 7 | 11 |
| 10–19 | 4 | 5 | 4 | 4 | 17 |
| 20–29 | 14 | 11 | 16 | 9 | 50 |
| 30–39 | 11 | 8 | 15 | 23 | 57 |
| 40–49 | 34 | 22 | 24 | 25 | 105 |
| 50–59 | 22 | 27 | 32 | 36 | 117 |
| 60–69 | 39 | 56 | 52 | 53 | 200 |
| 127 | 129 | 144 | 157 | 557 | |
| 70–79 | 47 | 68 | 53 | 61 | 229 |
| 80–89 | 144 | 205 | 188 | 229 | 766 |
| Total 70 years and over | 191 | 273 | 241 | 290 | 995 |
| Overall deaths and rate per 100000/year | 318 (1. 5) | 402(1.8) | 385 (1.7) | 449 (1.9) | 1552 |
Source: Australian Bureau of Statistics. Causes of death 2010.
Cases deemed to be asthma deaths examined from National Coroners Information System between 2005 and 2008 by age, gender and Socioeconomic Index For Areas (SEIFA)
| 2005 | 2006 | 2007 | 2008 | Overall | |
|---|---|---|---|---|---|
| Age | |||||
| 0–9 | 2 | 0 | 1 | 6 | 9 |
| 10–19 | 3 | 3 | 2 | 4 | 12 |
| 20–29 | 9 | 8 | 12 | 2 | 31 |
| 30–39 | 8 | 5 | 9 | 13 | 35 |
| 40–49 | 20 | 13 | 11 | 10 | 54 |
| 50–59 | 12 | 18 | 8 | 15 | 53 |
| 60–69 | 16 | 11 | 12 | 9 | 48 |
| Total under 70 | 70 | 58 | 56 | 59 | 243 |
| Gender | |||||
| Male | 39 | 25 | 28 | 34 | 126 |
| Female | 31 | 33 | 28 | 25 | 117 |
| Total | 70 | 58 | 56 | 59 | 243 |
| SEIFA | |||||
| −1000 | 18% (45) | 14% (33) | 16% (38) | 17% (41) | 65% (157) |
| +1000 | 10% (24) | 10% (25) | 7% (18) | 7% (18) | 35% (85) |
| Missing | 1 | ||||
| Total | 70 | 58 | 56 | 59 | 243 |
Figure 1Flow diagram of cases examined.
Characteristics of preventable/modifiable deaths
| Preventable or modifiable factors (n=169) | Non-preventable or modifiable factors (n=4) | Insufficient data to determine if death was preventable (n=70) | |
|---|---|---|---|
| Age (Mean±SD) | 43±17 | 57±10 | 46±17 |
| Gender | 90M 79F | 2M 2F | 34M 36F |
| SEIFA | 985±74 | 980±98 | 968±70 |
| Location of death | |||
| Home/friends (n=145) | 122 (84%) | 4 (3%) | 19 (13%) |
| Hospital/GP (n=20) | 14 (70%) | 0 | 6 (30%) |
| Ambulance/on way to hospital (n=13) | 12 (92%) | 0 | 1 (8%) |
| Public place (n=11) | 11 (100%) | 0 | 0 |
| Residential care (n=6) | 3 (50%) | 0 | 3 (50%) |
| Missing (n=47) | 8 (17%) | 0 | 39 (83%) |
| Psychosocial issues (n=106) | 93 (88%) | 2 (2%) | 11 (10%) |
| Drug and alcohol abuse (n=83) | 78 (85%) | 1 (1%) | 4 (4%) |
| Delay in seeking help (n=63) | 57 (89%) | 6 (9%) | |
| Respiratory tract infection (n=39) | 31 (80%) | 3 (7%) | 5 (13%) |
| Sudden onset (n=111) | 90 (81%) | 21 (19%) | |
SEIFA, Socioeconomic Index For Areas; GP, general practitioner.
Toxicology results.
| Drug | n | Mean concentration±SD | Normal values* |
|---|---|---|---|
| Alcohol—blood ethanol | 32 | 0.09±0.09 g/100 ml | <0.05 g/100 ml |
| Opiates/morphine/pethidine | 8 | 6±7 mg/l | 0.01–0.1 mg/l, 0.1–0.8 mg/l |
| Methadone | 7 | 0.8±0.3 mg/l | 0.1–0.5 mg/l |
| Amphetamine† | 7 | 0.15±0.15 mg/l | 0.02–0.1 mg/l |
| Tetrahydrocannabinol ‡ | 15 | 3±4.9 mg/l | 0.005–0.01 mg/l |
| Ketamine | 3 | 0.1, 0.7, 2.0 mg/l | 1–6 mg/l |
| Caffeine | 1 | 10 mg/l | 4–10 mg/l |
Critical Care 2012;16:R136 doi:10.1186/cc11441.
Toxicology examination was performed in 159 cases; 84 of these reports were accessible.
Toxicology reports were not available for the 26 West Australian cases or 49 cases in other states.
*Therapeutic (‘normal’), toxic and comatose-fatal blood-plasma concentrations (mg/l) in man.
†Amphetamine and/or methamphetamine.
‡Tetrahydrocannabinol.